Mumbai, June 29:
The recent border skirmishes with China, has led cent per cent examination of consignments from China, resulting into a huge backlog of imports at the Mumbai International Airport, Chennai airport and also sea ports including Goa, while traders are crying foul over delayed consignments.
Up till now nearly 70 per cent of Indian import consignments used to be checked through the automated route. However, since 23 June, any consignment coming from China is being subjected to 100 per cent manual checks at the Mumbai airport. The consignments include the consignments of mobile phones, medical equipments etc.
These stuck imports are creating hardships for traders and industry as their consignments are getting delayed for delivery and are also impacting production. The increased amount of checks by the customs are in light of the security concerns from China and the same SOP and procedure is being followed pan-India for all China imports.
A top official said that during such unusual circumstances an internal order is issued by respective Customs Commissioner based on advice of the Central Board of Indirect Taxes and Customs. Similarly the directions of World Trade Organisation are followed. Now the situation should improve gradually because there are also a sizable number of consignments of export from India to China.
In view of the backlog of consignments, the Federation of Indian Chambers and Commerce Industry (FICCI) and India Cellular and Electronics Association (ICEA) have written to the government seeking clarity on policy over imports from China.
In the meanwhile far from anti-China sentiments, the subject of import and export between India and China, is expected to remain complex since there is a regular supply chain between both the countries. 80 per cent of the Active Pharmaceutical Ingredients (API) (the central ingredient) are imported from China. Besides, there are many pharmaceutical units across India who have been routinely importing test kits and other medical equipments with ICMR approval, from the Chinese companies.
Many Indian pharma companies have been importing the Active Pharmaceutical Ingredients (API) (the central ingredient) from Chinese companies. Besides, there are many pharmaceutical units across India who have been routinely importing test kits and other medical equipments with ICMR approval, from the Chinese companies.
The list of Chinese companies from whom Indian entrepreneurs are in the process of procuring kits and medical equipments includes: Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics, M/s ShenzhenYHLO Biotech Co. Ltd., M/s Maccure Biotechnology .Ltd, M/s. Hangzhou Clongene Biotech Co.Ltd, M/s.Hangzhou All Test Biotech co Ltd, M/s Autobio Diag Co Ltd,M/s Shenzhen New Industries Biomedical Engineering (SNIBE),M/s Zhenghou Human well Biocel Technology Ltd, M/s. Getein Biotech Inc, M/s Beijing Genese Biotech Inc, M/s.Goldsite Diagnostics Inc, M/s.Dongguan Bosh Biotechnology, M/s Zybo Inc, M/sWuhan UN Science Biotechnology Co Ltd, M/s Hangzhou Biotech Co Ltd, M/s Changsha Sinocare Inc, and M/s Shanghai Fosun Long March.
Raju Vernekar is a Media Professional based in Mumbai and is a regular contributor of Imphal Times. He had served as Chief Reporter at Free Press Journal (1996 – 2015 ). His Activities includes writing for different news papers, script writing/production for TV channels, Films Division. Writing poems in Marathi, Hindi, English, Guiding mass media students and helping people to solve their problems. Raju may be contacted at [email protected]